Chronic spontaneous urticaria
Dupixent Fails to Win FDA Approval for Hives Disorder, Needs More Data
Anika Sharma
Regeneron and Sanofi have faced an unexpected hurdle in their pursuit of regulatory approval for Dupixent, a monoclonal antibody aimed ...
How Remibrutinib, a Novartis Drug, Can Heal Your Hives
SG Tylor
Source – Novartis Novartis has unveiled promising initial outcomes from the Phase III REMIX-1 and REMIX-2 trials assessing the effectiveness ...
